Clinical Trial Update: A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I trial of SSGJ-612 in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SSGJ-612

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: RECRUITING